David Goel 13F Holdings
Matrix Capital Management. Technology-focused hedge fund. Tiger Cub descendant.
As of the latest Q1 2026 filing, David Goel (managing Matrix Capital Management) reported a public portfolio value of $46.3M with 1 positions. The top recent sell was MAZE.
Open interactive portfolioDavid Goel 13F portfolio overview
David Goel's Q1 2026 13F holdings show Matrix Capital Management reporting 1 positions with a disclosed portfolio value of $46.3M. For readers searching David Goel 13F holdings, David Goel portfolio, or Matrix Capital Management holdings, the latest top holdings include AURA BIOSCIENCES.
The three largest reported positions add up to roughly 100.0%, which helps readers judge portfolio concentration rather than just headline AUM. The largest reported sector exposure is Other at 100.0% of the disclosed portfolio. This makes the page useful for comparing the manager's actual disclosed exposure with market narratives around the same names.
The latest change data highlights reported buys such as notable reported positions and reported reductions or exits such as MAZE THERAPEUTICS. Those changes should be read as historical disclosure signals, not as real-time trade alerts.
The filing metadata lists report date 2026-03-31, filing date 2026-05-14, SEC accession 0001172661-26-001967. SEC 13F reports are normally published up to 45 days after quarter end, so the data is best used to understand institutional positioning after the fact rather than to infer today's exact portfolio.
Top reported holdings
| Holding | Reported value | Weight | Quarter change |
|---|---|---|---|
| AURA whale holders AURA BIOSCIENCES INC | $46.3M | 100.0% | Held |
Top buys
No reported items for this period.
Top sells
- MAZE whale holders — MAZE THERAPEUTICS INC ($19.9M)
Allocation
- Other: 100.0%
Data notes
Report date: 2026-03-31
Disclosure source: SEC 13F
13F filings are delayed public disclosures and do not include every asset class, short positions, or real-time trades.
Related investor portfolios
- Bill Miller 13F portfolio — Miller Value Partners
- Seth Klarman 13F portfolio — Baupost Group
- Edgewood Management 13F portfolio — Edgewood Management LLC
- Joseph Edelman 13F portfolio — Perceptive Advisors
- John Griffin 13F portfolio — Blue Ridge Capital
- Baillie Gifford 13F portfolio — Baillie Gifford & Co
- Greenwoods 13F portfolio — Greenwoods Asset Management
- Alpine Associates 13F portfolio — Alpine Associates Management
Learn more in Whale Analyzer Academy
Frequently asked questions
What is David Goel buying?
The latest tracked change data for David Goel highlights reported buys such as notable reported positions. Because 13F data is historical, use it as a research trail rather than a live trade alert.
David Goel 13F portfolio
The Q1 2026 SEC 13F profile for David Goel and Matrix Capital Management shows 1 reported positions, $46.3M in disclosed portfolio value, and top holdings including AURA BIOSCIENCES.
Matrix Capital Management holdings
Matrix Capital Management holdings are summarized from public disclosures with reported values, weights, top buys, top sells, and filing metadata where available.
How delayed is David Goel's 13F data?
SEC Form 13F requires institutional investment managers with $100M+ in US equities to disclose their holdings quarterly. Read our comprehensive 13F guide.